CID 86574705

5'-ggggtgggt-3'

Structural Information

Molecular Formula
C90H112N39O57P9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)O)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C90H112N39O57P9/c1-30-12-121(89(140)119-73(30)131)50-3-32(130)41(170-50)14-162-188(145,146)181-35-6-53(124-24-99-60-67(124)106-83(92)113-76(60)134)173-44(35)17-166-192(153,154)185-39-10-57(128-28-103-64-71(128)110-87(96)117-80(64)138)177-48(39)21-168-193(155,156)183-37-8-55(126-26-101-62-69(126)108-85(94)115-78(62)136)174-45(37)18-164-189(147,148)179-33-4-51(122-13-31(2)74(132)120-90(122)141)171-43(33)16-163-191(151,152)182-36-7-54(125-25-100-61-68(125)107-84(93)114-77(61)135)176-47(36)20-167-195(159,160)186-40-11-58(129-29-104-65-72(129)111-88(97)118-81(65)139)178-49(40)22-169-194(157,158)184-38-9-56(127-27-102-63-70(127)109-86(95)116-79(63)137)175-46(38)19-165-190(149,150)180-34-5-52(172-42(34)15-161-187(142,143)144)123-23-98-59-66(123)105-82(91)112-75(59)133/h12-13,23-29,32-58,130H,3-11,14-22H2,1-2H3,(H,145,146)(H,147,148)(H,149,150)(H,151,152)(H,153,154)(H,155,156)(H,157,158)(H,159,160)(H,119,131,140)(H,120,132,141)(H2,142,143,144)(H3,91,105,112,133)(H3,92,106,113,134)(H3,93,107,114,135)(H3,94,108,115,136)(H3,95,109,116,137)(H3,96,110,117,138)(H3,97,111,118,139)
InChIKey
PIUHAUQXPGHUKM-UHFFFAOYSA-N
Compound name
[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl] [3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2929.4702 Da
Monoisotopic Mass

-21.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2930.4775 283.0
[M+Na]+ 2952.4594 286.5
[M-H]- 2928.4629 283.2
[M+NH4]+ 2947.5040 284.2
[M+K]+ 2968.4334 284.8
[M+H-H2O]+ 2912.4675 282.7
[M+HCOO]- 2974.4684 284.6
[M+CH3COO]- 2988.4841 285.2
[M+Na-2H]- 2950.4449 289.0
[M]+ 2929.4697 284.9
[M]- 2929.4707 284.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.